In quarter 1 of 2020, there were 77 participants including both domestic and international programs enrolled in the CF DNA PT program, eight of which identified that their programs use NGS technology either to sequence the coding regions of the CFTR gene or to identify a large number of pathogenic variants [17]. The gene discussed is CFTR; the disease is cystic fibrosis.